A new case report details a novel genetic mutation linked to drug resistance in a non-small cell lung cancer patient ...

A new case report was published in Volume 16 of Oncotarget on February 5, 2025, titled “Acquired RUFY1-RET rearrangement as a ...

Here we present a case of a patient with stage IV CD-74-ROS1 fusion NSCLC discovered initially with RNA next generation sequencing (NGS) who acquired ...

The following is a summary of “Sex-based differences in lung cancer susceptibility and molecular genetics in the 2020s,” published in the January 2025 issue of Pulmonology by Mosleh et al. Sex-based ...

Explore how genetic testing and precision oncology are revolutionizing cancer treatment by offering personalized care and ...

Molecular profiling and genetic testing have revolutionised lung cancer treatment, says a doctor. They have enabled targeted therapies that are more effective and tolerable than traditional ...

In this video, Xiuning Le, MD, PhD, discusses how the definition of EGFR-mutated lung cancer has expanded in recent years.

A new study from Moffitt Cancer Center could help doctors predict how well patients with a specific type of lung cancer will ...

Groundbreaking personalized kidney cancer vaccines show promise in early clinical trials, triggering strong immune responses ...

Lung cancer has become a major health concern in India, attributed to air pollution, smoking, and genetic factors. Early ...

The global cancer diagnostics market size was valued at USD 106.32 billion in 2024 and is projected to reach from USD 112.60 ...

Lung cancer cases among non-smokers are rising, driven by factors like air pollution, second-hand smoke, and genetic ...